On November 12th and 13th, the Spanish Wilson disease association of patients and patients’ families is holding its annual conference in Valencia, Spain.

On that occasion, Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO and FIMA Deputy Director will give an update on the development of gene therapies for Wilson disease. Don’t miss her talk on Saturday November 12th, from 10:45-11:15 am.